Published in Int J Mol Cell Med on January 01, 2015
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun (1998) 3.76
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis (2001) 2.41
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis (1997) 2.32
Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell (1997) 1.93
Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect (2013) 1.86
Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep (1995) 1.81
Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol (2009) 1.79
Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev (2008) 1.65
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Pertussis vaccine: present status and future prospects. Vaccine (1985) 1.63
Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis (2002) 1.58
Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology (2001) 1.56
Bordetella pertussis and pertussis vaccines. Clin Infect Dis (2009) 1.48
Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine (2001) 1.42
Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis (2000) 1.37
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol (2004) 1.32
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol (2007) 1.14
Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. Proc Natl Acad Sci U S A (1992) 1.12
Pertussis in Argentina and France. Vaccine (2006) 1.10
Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine (2006) 1.06
Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05
Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran. Iran J Microbiol (2013) 0.85
Serologic evidence of pertussis infection in vaccinated Iranian children. Iran J Med Sci (2012) 0.83
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82
The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J Microbiol Methods (2003) 0.81
Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial. Hum Vaccin Immunother (2013) 0.80